Pneumonias (Asthma/COPD co-morbidities)


pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector

Filter registries None


diagram downward connector

Check pre-conditions, main-only, mode, ICD version None


diagram downward connector

Check minimum number of events None


diagram downward connector

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Pneumonias (Asthma/COPD co-morbidities) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 43583 18652 24931
Unadjusted prevalence (%) 14.13 10.75 18.46
Mean age at first event (years) 55.84 52.05 58.68


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.09 7.70 [7.02, 8.44] <1e-100 11590
15 years 0.01 2.70 [2.44, 2.98] 4.1e-85 2434
5 years 0.01 7.17 [6.60, 7.79] <1e-100 3258
1 year 0.01 40.98 [36.83, 45.60] <1e-100 5451

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: PNEUMONIA – Pneumonias (Asthma/COPD co-morbidities)
GWS hits:

Survival analyses between endpoints


before Pneumonias (Asthma/COPD co-morbidities)
after Pneumonias (Asthma/COPD co-morbidities)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Pneumonias (Asthma/COPD co-morbidities)